Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LAMIVUDINE 3TC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 19 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    3. Saif, MW; Little, RF; Hamilton, JM; Allegra, CJ; Wilson, WH
      Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: A case report and review of the literature

      ANNALS OF ONCOLOGY
    4. Urban, S; Urban, S; Fischer, KP; Tyrrell, DL
      Efficient pyrophosphorolysis by a hepatitis B virus polymerase may be a primer-unblocking mechanism

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Miller, V; Ait-Khaled, M; Stone, C; Griffin, P; Mesogiti, D; Cutrell, A; Harrigan, R; Staszewski, S; Katlama, C; Pearce, G; Tisdale, M
      HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy

      AIDS
    6. Harrigan, PR; Stone, C; Griffin, P; Najera, I; Bloor, S; Kemp, S; Tisdale, M; Larder, B
      Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy

      JOURNAL OF INFECTIOUS DISEASES
    7. Caputo, R; Guaragna, A; Palumbo, G; Pedatella, S
      A new strategy for the asymmetric synthesis of 1,3-oxathiolane-based nucleoside analogues

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    8. Calamandrei, G; Venerosi, A; Branchi, I; Valanzano, A; Puopolo, M; Alleva, E
      Neurobehavioral effects of prenatal lamivudine (3TC) exposure in preweaning mice

      NEUROTOXICOLOGY AND TERATOLOGY
    9. Schuurman, R; Demeter, L; Reichelderfer, P; Tijnagel, J; de Groot, T; Boucher, C
      Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase

      JOURNAL OF CLINICAL MICROBIOLOGY
    10. Zhou, XJ; Sheiner, LB; D'Aquila, RT; Hughes, MD; Hirsch, MS; Fischl, MA; Johnson, VA; Myers, M; Sommadossi, JP
      Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. HOETELMANS RMW; PROFIJT M; MEENHORST PL; MULDER JW; BEIJNEN JH
      QUANTITATIVE-DETERMINATION OF (-)-2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN HUMAN PLASMA, SALIVA AND CEREBROSPINAL-FLUID BY HIGH-PERFORMANCELIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION

      Journal of chromatography B. Biomedical sciences and applications
    12. PEIRO VO; VIEDMA BL; CORTIJO JC
      NEW ANTIVIRAL DRUGS IN THE TREATMENT OF C HRONIC HEPATITIS-B AND HEPATITIS-C

      Revista espanola de enfermedades digestivas
    13. KEMP SD; SHI CF; BLOOR S; HARRIGAN PR; MELLORS JW; LARDER BA
      A NOVEL POLYMORPHISM AT CODON-333 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CAN FACILITATE DUAL RESISTANCE TO ZIDOVUDINEAND L-2',3'-DIDEOXY-3'-THIACYTIDINE

      Journal of virology
    14. NIJHUIS M; SCHUURMAN R; BOUCHER CAB
      HOMOLOGOUS RECOMBINATION FOR RAPID PHENOTYPING OF HIV

      Current opinion in infectious diseases
    15. SCHUURMAN R
      STATE-OF-THE-ART OF GENOTYPIC HIV-1 DRUG-RESISTANCE

      Current opinion in infectious diseases
    16. SOLDER B; WINTERGERST U; NOTHEIS G; EBERLE J; GURTLER L; BELOHRADSKY BH
      EFFECT OF ANTIRETROVIRAL COMBINATION THERAPY (ZIDOVUDINE DIDANOSINE OR ZIDOVUDINE/LAMIVUDINE) ON QUANTITATIVE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID IN CHILDREN AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/

      The Journal of pediatrics
    17. ROULEAU D; CONWAY B; RABOUD J; RAE S; FRANSEN S; SHILLINGTON A; ZALA C; OSHAUGHNESSY MV; MONTANER JSG
      STAVUDINE PLUS LAMIVUDINE IN ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - A SHORT-TERM PILOT-STUDY

      The Journal of infectious diseases
    18. ROBBINS BL; WAIBEL BH; FRIDLAND A
      QUANTITATION OF INTRACELLULAR ZIDOVUDINE PHOSPHATES BY USE OF COMBINED CARTRIDGE RADIOIMMUNOASSAY METHODOLOGY

      Antimicrobial agents and chemotherapy
    19. MAHMOUDIAN M; BAINES BS; DRAKE CS; HALE RS; JONES P; PIERCEY JE; MONTGOMERY DS; PURVIS IJ; STORER R; DAWSON MJ; LAWRENCE GC
      ENZYMATIC PRODUCTION OF OPTICALLY PURE (2'R-CIS)-2'-DEOXY-3'-THIACYTIDINE (3TC, LAMIVUDINE) - A POTENT ANTI-HIV AGENT

      Enzyme and microbial technology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 21:30:31